Altered Metabolism: A Major Contributor of Comorbidities in Neurodegenerative Diseases

This book presents a systematic and extensive understanding about metabolic alterations affecting multiple aspects of different neurodegenerative diseases (NDDs), such as Alzheimer’s, Parkinson’s, Huntington’s disease, SCAs, SBMA, DRPLA, ALS, Freidrich Ataxia etc. The book also illustrates cellular...

Whakaahuatanga katoa

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Kaituhi rangatōpū: SpringerLink (Online service)
Ētahi atu kaituhi: Agrawal, Namita (Editor)
Hōputu: Tāhiko īPukapuka
Reo:Ingarihi
I whakaputaina: Singapore : Springer Nature Singapore : Imprint: Springer, 2024.
Putanga:1st ed. 2024.
Ngā marau:
Urunga tuihono:https://doi.org/10.1007/978-981-97-4288-2
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
Rārangi ihirangi:
  • Chapter 1: An Overview of Neurodegenerative Disorders
  • Chapter 2: Mechanism underlying major neurodegenerative disorders
  • Chapter 3: Involvement of metabolic paradigm in progression of neurodegenerative diseases
  • Chapter 4: Glial cell metabolism and neurodegenerative diseases: The current perspective
  • Chapter 5: Altered glucose homeostasis in neurological disorders
  • Chapter 6: Lipid Metabolism: Key Determinant in Neurodegenerative Diseases
  • Chapter 7 - Dysregulated peripheral metabolism in neurodegenerative disorders
  • Chapter 8- Protein Metabolism: Critical factors implicated in neurodegenerative diseases
  • Chapter 9 - Altered RNA metabolism in neurodegenerative disorders
  • Chapter 10: Unveiling RNA dysfunction: A key player in neurodegeneration
  • Chapter 11: Emerging Relationship between the Gut Microbiota and Neurodegenerative Disorders
  • Chapter 12- Signaling Pathways in Neurodegenerative diseases
  • Chapter 13: An overview of imaging techniques for diagnosis of debilitating neurodegenerative diseases
  • Chapter 14: Novel Metabolic Biomarkers and Therapeutic Strategies in Neurodegenerative Diseases
  • Chapter 15: Phytochemicals: Promising alternatives for metabolic regulation in neurodegenerative diseases.